North American Vaccine, Chiron Behring GmbH & Co. sales and marketing update

NVX said that Chiron Behring is seeking to terminate its agreement to market NVX's Certiva DTaP and DTaP-IPV vaccines in Germany and Austria. NVX said it will dispute the termination If discussions with Chiron Behring fail to resolve the issue. The vaccines are approved in the EU. ...